Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Depreciation & Amortization (CF) (2014 - 2023)

Mesoblast's (MEOBF) quarterly Depreciation & Amortization (CF) came in at $927000.0 in Q2 2023, down 13.45% year-over-year from $1.1 million in Q2 2022, and down 6.36% quarter-over-quarter from $990000.0 in Q1 2023.

Analysis

Mesoblast (MEOBF) Depreciation & Amortization (CF) (2014 - 2023) Analysis & Trends

Mesoblast has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $927000.0 for Q2 2023.

  • In Q2 2023, Depreciation & Amortization (CF) fell 13.45% year-over-year to $927000.0; the TTM figure through Dec 2024 stood at $927000.0 (down 69.12% YoY), while the FY2026 annual figure was $8.6 million, up 34.14% from the prior year.
  • Depreciation & Amortization (CF) came in at $927000.0 for Q2 2023 at Mesoblast, down from $990000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.7 million in Q1 2020 to a low of $531000.0 in Q1 2019.
  • Average Depreciation & Amortization (CF) over 5 years is $1.2 million, with a median of $1.1 million recorded in 2021.
  • Year-over-year, Depreciation & Amortization (CF) soared 588.76% in 2019 and slumped 59.3% in 2021.
  • Over 5 years, Depreciation & Amortization (CF) stood at $1.7 million in 2019, then tumbled by 38.95% to $1.0 million in 2020, then advanced by 5.25% to $1.1 million in 2021, then fell by 1.54% to $1.1 million in 2022, then retreated by 14.56% to $927000.0 in 2023.
  • Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $927000.0 in Q2 2023, $990000.0 in Q1 2023, and $1.1 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 4.28 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 3.78 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 4.00 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 4.91 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 5.41 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 1.10 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 10.41 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 3.62 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 927,000.00
Mar 31, 2023 990,000.00
Dec 31, 2022 1.09 Mn
Sep 30, 2022 1.11 Mn
Jun 30, 2022 1.07 Mn
Mar 31, 2022 1.11 Mn
Dec 31, 2021 1.10 Mn
Sep 30, 2021 1.09 Mn
Jun 30, 2021 1.13 Mn
Mar 31, 2021 1.08 Mn
Dec 31, 2020 1.05 Mn
Sep 30, 2020 1.01 Mn
Mar 31, 2020 2.66 Mn
Dec 31, 2019 1.72 Mn
Sep 30, 2019 849,000.00
Mar 31, 2019 531,000.00
Dec 31, 2018 249,000.00
Sep 30, 2018 554,000.00
Jun 30, 2018 586,000.00
Mar 31, 2018 832,000.00